Nature子刊:微生物组疗法想要成功,少不了这个方法
(滑动下方文字查看)
1. Vázquez-Castellanos, J. F., Biclot, A., Vrancken, G., Huys, G. R. & Raes, J. Design of synthetic microbial consortia for gut microbiota modulation. Curr. Opin. Pharmacol. 49, 52–59 (2019).
2. El Hage, R., Hernandez-Sanabria, E. & Van de Wiele, T. Emerging trends in “smart probiotics”: functional consideration for the development of novel health and industrial applications. Front. Microbiol. 8, 1889 (2017).
3. Clemente, J. C., Manasson, J. & Scher, J. U. The role of the gut microbiome in systemic inflammatory disease. BMJ 360, j5145 (2018).
4. Mills, S., Ross, R. P. & Hill, C. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology. FEMS Microbiol. Rev. 41, S129–S153 (2017).
5. Vieira-Silva, S. et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 581, 310–315 (2020).
6. Vrancken, G., Gregory, A. C., Huys, G. R., Faust, K. & Raes, J. Synthetic ecology of the human gut microbiota. Nat. Rev. Microbiol. 17, 754–76 (2019).
7. Tramontano, M. et al. Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies. Nat. Microbiol. 3, 514–522 (2018).
8. Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).
9. Hernandez-Sanabria, E. et al. Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation. NPJ Biofilms Microbiomes 6, 1–12 (2020).
10. Muller, E. E. et al. Using metabolic networks to resolve ecological properties of microbiomes. Curr. Opin. Syst. Biol. 8, 73–80 (2018).
原文链接:https://www.nature.com/articles/s41575-020-00364-7
作者|Emma Hernandez-Sanabria、Jorge Francisco Vázquez-Castellanos and Jeroen Raes